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Abstract 21 
Mupirocin is a polyketide antibiotic with broad antibacterial activity. It was isolated 22 
and characterized about 40 years ago from Pseudomonas fluorescens NCIMB 10586. To 23 
study the phylogenetic distribution of mupirocin producing strains in the genus Pseudomonas 24 
a large collection of Pseudomonas strains of worldwide origin, consisting of 117 25 
Pseudomonas type strains and 461 strains isolated from different biological origins, was 26 
screened by PCR for the mmpD gene of the mupirocin gene cluster. Five mmpD+ strains from 27 
different geographic and biological origin were identified. They all produced mupirocin and 28 
were strongly antagonistic against Staphylococcus aureus. Phylogenetic analysis showed that 29 
mupirocin production is limited to a single species.  30 
Inactivation of mupirocin production leads to complete loss of in vitro antagonism 31 
against S. aureus, except on certain iron-reduced media where the siderophore pyoverdine is 32 
responsible for the in vitro antagonism of a mupirocin-negative mutant. In addition to 33 
mupirocin some of the strains produced lipopeptides of the massetolide group. These 34 
lipopeptides do not play a role in the observed in vitro antagonism of the mupirocin producing 35 
strains against S. aureus. 36 
 37 
Key words: mupirocin; massetolide; pyoverdine, Pseudomonas fluorescens NCIMB 10586; 38 
Pseudomonas sp. W2Aug9 39 
  40 
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1. Introduction 41 
Mupirocin is a polyketide antibiotic which has been isolated and characterized from 42 
the soil bacterium P. fluorescens NCIMB 10586 [1]. In fact mupirocin is a mixture of four 43 
pseudomonic acids (A-D). The basic structure of mupirocin comprises a monic acid (a 44 
heptaketide) containing a pyran ring, attached to 9-hydroxynonanoic acid via an ester linkage 45 
[2]. Mupirocin has a broad spectrum activity against both Gram-positive and Gram-negative 46 
bacteria, although most Gram-negative bacteria tested are less susceptible than Gram-positive 47 
bacteria [3]. The antibiotic acts through the inhibition of bacterial isoleucyl-tRNA synthetase 48 
[4]. Mupirocin is currently used topically for the treatment of skin infections, impetigo and for 49 
the decolonization of patients with nasal carriage of Staphylococccus [5].  50 
Although the biosynthetic pathway and the antimicrobial activity of mupirocin have 51 
been extensively studied [6], the strain producing this antibiotic is not well characterized. The 52 
taxonomic position of strain P. fluorescens NCIMB 10586 is not known since its 16S rRNA 53 
gene nor any other housekeeping gene have been sequenced yet. It is also not known whether 54 
the ability to produce mupirocin is widespread throughout the genus Pseudomonas or limited 55 
to only a few species. Besides P. fluorescens NCIMB 10586, another two mupirocin 56 
producing strains, strain D7 and G11 isolated from groundwater sediment samples, have been 57 
reported [7]. Both strains were allocated to the P. fluorescens group [7] based on their 16S 58 
rRNA sequence.  59 
The aim of this study was dual; first to assess the distribution of mupirocin producing 60 
Pseudomonas spp. throughout the genus Pseudomonas and to subsequently study their 61 
diversity. Therefore a specific mupirocin primer set was developed based on the mmpD gene. 62 
This multifunctional gene is involved in the synthesis of the backbone of monic acid. A large 63 
collection of Pseudomonas type strains and partially identified environmental strains 64 
representing a high phylogenetic diversity was screened using the mupirocin primer set. 65 
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Mupirocin production was confirmed through isolation and identification of the antibiotic and 66 
in vitro antagonism tests against Staphylococcus aureus. The second part of the work focused 67 
on the mupirocin producing strains themselves whereby it was investigated whether the 68 
strains produce additional well-known antimicrobial metabolites and extracellular enzymes to 69 
gain insight in their antimicrobial potential. The respective role of the antimicrobial 70 
compounds in the in vitro antagonism against S. aureus was further investigated via 71 
transposon mutagenesis. 72 
 73 
2. Material and Methods 74 
2.1. Bacterial strains 75 
A total of 578 strains and isolates from different biological origins were studied. These 76 
included 117 type strains of the genus Pseudomonas (listed in Supplementary Table S1) and a 77 
collection of 198 Pseudomonas isolates from the River Woluwe, which were isolated from the 78 
source (site W2) and the mouth of the river (site W15) (Supplementary Table S2 in [8]). In 79 
addition, a collection of 48 Pseudomonas non type strains obtained from different culture 80 
collections (Supplementary Table S2) were included together with 215 strains and isolates 81 
received from different laboratories (Supplementary Table S3). 82 
 83 
2.2. Growth conditions 84 
The Pseudomonas strains (Table 1) were routinely grown at 28°C on an in house 85 
medium, medium 853, composed of 10 g l-1 bacto tryptone, 5 g l-1 yeast extract, 5 g l-1 NaCl, 1 86 
g l-1 glucose, 0.7 g l-1 K2HPO4 and 0.3 g l-1 KH2PO4. Escherichia coli SM10 (λpir) was grown 87 
in 853 at 37°C. Gentamicin (Gm) was used at a concentration of 50 µg ml-1 (P. fluorescens 88 
NCIMB 10586) or 200 µg ml-1 (Pseudomonas sp. W2Aug9), chloramphenicol (Cm) was used 89 
at a concentration of 25 µg ml-1. Antagonism tests were performed on 4 different media; 90 
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medium 853, blood agar (BBLTM Blood agar Base [Becton, Dickinson and company] with 5 91 
% of defibrinated sheep blood), Mueller-Hinton agar (MH) (Difco Laboratories) and GCA 92 
medium [9]. When required GCA was supplemented with FeCl3 to a final concentration of 93 
100 µM (GCA+Fe medium). Pyoverdine detection and purification was done on iron-poor 94 
casamino acids (CAA) medium [10]. 95 
 96 
2.3. Screening for mupirocin producing strains by PCR 97 
During a PCR screening of 195 Pseudomonas strains for the antibiotic pyoluteorin 98 
with the primer set PltBf and PltBr [11] two false positives were picked up of which the 99 
nucleotide sequence aligned with part of the mmpD gene sequence (position 21309-22090) of 100 
the mupirocin gene cluster of P. fluorescens NCIMB 10586 (accession number AF318063). 101 
Comparing the sequence of the PltBf-r primer set with the complementary sequence of the 102 
mmpD gene of P. fluorescens NCIMB 10586 showed that there was only 1 mismatch with the 103 
PltBf primer and several for the PltBr primer (Supplementary Fig. S1). The combination of 104 
one almost perfect primer with the relatively low annealing temperature during the 105 
amplification can explain why mmpD fragments were obtained during the screening with the 106 
pyoluteorin primer set. A specific mupirocin primer set (MUP-F1: 5’-107 
CGGATCATGGACCCCCAGC-3’ and MUP-R1: 5’-CAGGCCTTGGATCTCGATAG-3’) 108 
was developed on the basis of the PltBf primer and the mmpD sequences of P. fluorescens 109 
NCIMB 10586 and the 2 candidates obtained through the screening with the pyoluteorin 110 
primer set. They amplify a fragment of 717 bp. All 578 strains and isolates were screened 111 
with MUP-F1 and MUP-R1. The PCR was carried out in a final volume of 25 µl containing 112 
PCR buffer (Qiagen) with 0.625 U Taq DNA polymerase (Qiagen), 5 µl Q-solution (Qiagen), 113 
the deoxynucleotide mixture at 100 µM (Fermentas), each of the primers at 0.5 µM (Sigma) 114 
and 1-2 µl template DNA. Template DNA for PCR reaction was prepared by inoculating a 115 
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fresh colony in 25 µl water and heating it for 5 min at 95°C. The PCR program used was an 116 
initial denaturation of 2 min at 94°C, followed by 40 cycles of denaturation at 94°C for 30 s, 117 
annealing at 50°C for 30 s and extension at 72°C for 50 s, followed by an incubation for 10 118 
min at 72°C. P. fluorescens NCIMB 10586 was used as positive control. The obtained PCR 119 
fragments were sequenced directly using the amplification primers at Beckman Coulter 120 
Genomics (UK). The accession numbers of the mmpD fragment of P. fluorescens LMG 121 
14677, Pseudomonas sp. W2Aug9, W2Jun17, W15Feb34 and B329 are KJ528554, 122 
KJ528555, KJ528556, KJ528557 and KJ528558, respectively. 123 
 124 
2.4. Mupirocin production 125 
Mupirocin was purified from the culture supernatant as described in [12]. The 126 
presence of the antibiotic was determined by HPLC with a reverse-phased C18 Altima 127 
(GRACE) column (250 mm x 4.6 mm, 10 µM), using the conditions as described in [12]. 128 
Mupirocin was detected at 27.6 min. Pure mupirocin (Sigma) was used as control. 129 
 130 
2.5 PCR for the tailoring enzymes of the mupirocin gene cluster 131 
To detect the genes responsible for the maturation of pseudomonic acid A in the five 132 
mupirocin producing strains 26 primer sets (Supplementary Table S4) were developed to 133 
amplify part of these genes. PCR was done with DreamTaq Green (Thermo Scientific) using 134 
the same conditions as for the mupirocin PCR. P. fluorescens NCIMB 10586 was used as 135 
positive control. For primer set mupU-F/R the PCR was done at 59°C since lower 136 
temperatures gave an amplicon of lower size for Pseudomonas sp. W2Aug9, W2Jun17 and P. 137 
fluorescens LMG 14677.  138 
 139 
2.6. 16S rRNA and rpoB gene amplification and sequencing 140 
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The almost complete 16S rRNA gene sequence (position 29 to 1522 in E. coli) of the 141 
mmpD+ Pseudomonas strains was amplified with primers pA and pH [13]. The PCR mix was 142 
prepared using the same conditions as described for the mupirocin PCR with the difference 143 
that the PCR was carried out in a final volume of 100 µl and the amount of template was 144 
increased to 3 µl. The PCR program used was an initial denaturation of 2 min at 94°C, 145 
followed by 30 cycles of denaturation at 94°C for 30 sec, annealing at 55°C for 30 sec and 146 
extension at 72°C for 90 s, followed by an incubation for 10 min at 72°C. The accession 147 
numbers of P. fluorescens NCIMB 10586, P. fluorescens LMG 14677, Pseudomonas sp. 148 
W2Aug9, Pseudomonas sp. W2Jun17, Pseudomonas sp. W15Feb34 and Pseudomonas sp. 149 
B329 are KJ528545, GU198127, KJ528546, KJ528547, EU681017, KJ528548, respectively. 150 
The housekeeping gene rpoB was amplified using primers LAPS and LAPS27 [14] using the 151 
same conditions as for the mupirocin PCR, except that the elongation time was increased to 1 152 
min 20 s. The obtained PCR fragments were purified and sequenced at Beckman Coulter 153 
Genomics (UK) using amplification and internal primers (for 16S rRNA). 154 
 155 
2.7. Phylogenetic analysis 156 
Phylogenetic analysis based on almost complete 16S rRNA gene sequences and partial 157 
rpoB genes were performed using CLUSTALX and MEGA v5.0 [15]. The neighbor-joining 158 
method was used with the Jukes-Cantor model and topological robustness was evaluated by 159 
bootstrap analysis based on 1.000 replicates. The 16S rRNA gene sequences of the type 160 
strains and the rpoB gene of P. aeruginosa LMG 1242T were taken from GenBank.  161 
 162 
2.8. Antibiotic and HCN production 163 
Detection of the genes responsible for the production of hydrogen cyanide (HCN) [16] 164 
and antibiotics was done by PCR using gene-specific primers. The antibiotics of interest are 165 
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2,4-diacetylphloroglucinol [17], pyrrolnitrin [17] and phenazine-1-carboxylic acid [18]. The 166 
same conditions as for the mupirocin PCR were used except that the elongation time was 167 
adapted to the size of the fragment. P. protegens Pf-5 was used as positive control. 168 
 169 
2.9. Protease production 170 
Protease activity was detected as clearing zones on skim milk agar plates [19]. 171 
 172 
2.10. Pyoverdine production 173 
Pyoverdine production was verified by measuring the OD at 405nm of the culture 174 
supernatant of the cells grown in CAA medium for 48 h at 28°C, 200 RPM. The pyoverdine 175 
was semi-purified as described in [20] and identified through a combination of mass analysis 176 
and IEF [20].  177 
 178 
2.11. Production and identification of lipopeptides 179 
Surfactant production was verified through the drop collapse assay. Therefore 180 
bacterial cells were grown for 24h and 10 µl droplets of the culture or the culture supernatant 181 
were spotted on parafilm. A flat droplet was indicative of lipopeptide production. Hemolytic 182 
activity was detected as a lysis zone surrounding colonies grown for 3 days at 28°C on blood 183 
agar.  184 
Lipopeptides were analyzed from supernatant samples with a UPLC (Acquity H-class, 185 
Waters s.a., Zellik, Belgium) coupled to a single quadrupole mass spectrometer (Waters SQD 186 
mass analyzer) on a ACQUITY UPLC® BEH C18 1.7 µm column. Ten µl was injected and 187 
elution was performed at 40°C with a constant flow rate of 0.6 ml min-1 using a gradient of 188 
acetonitrile in water both acidified with 0.1% formic acid as follows: 0.5 min at 0%, from 0% 189 
to 15% in 2 min, from 15% to 95% in 5 min and maintained at 95% for 1.8 min. Compounds 190 
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were detected as protonated molecular ions detected in electrospray positive ion mode (scan 191 
in the mass range m/z 950-1250) by setting SQD parameters as follows: source temperature 192 
130°C; desolvation temperature 300°C, and desolvation/cone nitrogen flow: 1000/50 l h-1. For 193 
optimal detection, the cone voltage was set at 80V. The same conditions were used for 194 
analysis of lipopeptide in source-fragmentation but the cone voltage was increased to 120V. 195 
 196 
2.12. In vitro antagonism assays against S. aureus 197 
The in vitro antagonism of the mupirocin producing Pseudomonas strains against S. 198 
aureus 383, a clinical strain isolated from infected femoral pin [21] was tested on 853 agar, 199 
blood agar, MH agar, GCA and GCA amended with 100 µM Fe. Five µl of OD600 = 0.5 of the 200 
Pseudomonas strain was inoculated in the center of the plate. The plates were incubated at 201 
28°C and after 2 days the cells were killed using chloroform vapors for 25 min. After 202 
evaporation of the chloroform a 6 ml overlay of soft agar (0.7% agar) of 853 with 5 x 106 203 
cells of S. aureus 383, was overlaid on the plate which was subsequently incubated at 37°C. 204 
Clear zones of inhibition were measured the next day. All antagonism assays were performed 205 
at least two times with 3 replicas. 206 
 207 
2.13. Transposon mutagenesis and screening for a hemolytic-negative mutant of 208 
Pseudomonas sp. W2Aug9 209 
The suicide plasmid pUT, which harbors the transposon mini-Tn5phoA3 (GmR) [22] 210 
was used to generate transposon insertions in the chromosome of Pseudomonas sp. W2Aug9. 211 
Mid-log phase cultures of E. coli SM10 (λpir), the host of pUT-mini-Tn5phoA3, was mixed 212 
with strain W2Aug9 in a 1:1 ratio. The Pseudomonas strain was kept at 37°C for 1 h just 213 
before mixing with E. coli in order to inactivate its restriction system. After overnight 214 
incubation on 853 at 28°C, Tn5 insertions were selected on CAA supplemented with 25 µg 215 
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ml-1 Cm and 200 µg ml-1 Gm. A small bank of 468 transconjugants was established to screen 216 
for mutants showing complete loss of hemolytic activity by inoculating with a toothpick 217 
mutants on a blood agar plate followed by incubation for 2 days at 28°C. Hemolytic-negative 218 
candidates were subsequently verified for protease production. 219 
 220 
2.14. Transposon mutagenesis and screening for an antagonism-negative mutant of 221 
10586∆AT2 222 
An antagonism-negative mutant of the mupirocin-negative strain 10586∆AT2 of P. 223 
fluorescens NCIMB 10586 was obtained through Tn5 mutagenesis on 10586∆AT2 using 224 
mini-Tn5phoA3 as described in 2.13, with the modification that the transconjugants were 225 
plated on a lower Gm concentration (50 µg ml-1). A library of 2000 candidates was screened 226 
for complete loss of in vitro antagonism against S. aureus 383. Therefore the candidates were 227 
grown overnight at 28°C in medium 853 in microtiter plates whereby every two wells were 228 
inoculated, alternating between an inoculated and not inoculated well. The cultures were 229 
replicated on 853 medium and incubated for 16h at 28°C. An overlay of S. aureus 383 was 230 
prepared as explained in paragraph 2.12.  231 
 232 
2.15. Transposon mutagenesis and screening for a pyoverdine-negative mutant of P. 233 
fluorescens NCIMB 10586 234 
A pyoverdine-negative mutant of P. fluorescens sp. NCIMB 10586 was obtained 235 
through Tn5 mutagenesis using mini-Tn5phoA3 as described in 2.13. Tn5 insertions were 236 
selected on CAA supplemented with 50 µg ml-1 Gm and 25 µg ml-1 Cm. A bank of 576 237 
transconjugants was screened for complete loss of fluorescence in the iron-limiting media 238 
CAA.  239 
 240 
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2.16. Molecular characterization of the Tn5 mutants 241 
The chromosomal DNA was isolated using the DNeasy Blood & Tissue kit (Qiagen), 242 
digested with PstI or SalI (Fermentas) and self-ligated. The DNA flanking the mini-Tn5phoA3 243 
was isolated and sequenced as described earlier [23].  244 
 245 
3. Results 246 
3.1. Screening for mupirocin producing strains 247 
578 Pseudomonas strains were screened by PCR for presence of part of the mmpD 248 
gene fragment. Five strains (0.9% of the collection) gave an amplicon. Three of these strains 249 
(W2Aug9, W2Jun17 and W15Feb34) were from the Woluwe River collection [8]. In addition 250 
the mmpD gene fragment was amplified from P. fluorescens LMG 14677 and Pseudomonas 251 
sp. B329, a grass rhizosphere isolate. Sequencing of the mmpD fragments of the 5 candidates 252 
and alignment with the gene of P. fluorescens NCIMB 10586 revealed that Pseudomonas sp. 253 
W15Feb34 and B329 have identical sequences to NCIMB 10586, W2Aug9 has a C→T 254 
transition at position 255 of the amplified fragment and P. fluorescens LMG 14677, W2Jun17 255 
and W2Aug9 an A→G transversion at position 489. These differences do not alter the amino 256 
acid sequence.  257 
Purification of mupirocin from these strains and analysis by HPLC confirmed that they 258 
all produce the antibiotic. Mass analysis of the obtained peaks identified pseudomonic acid A 259 
and B for all the strains (Supplementary Fig. S2). In contrast to what has been reported 260 
previously [6] whereby pseudomonic acid B represented only a minor fraction of the mixture 261 
(8%), higher levels of pseudomonic acid B were found (relative abundance between 29 and 262 
61%) in all producing strains including P. fluorescens NCIMB 10586. This is probably due to 263 
differences in growth conditions and/or media. PCR with primers specific for the tailoring 264 
genes of the mupirocin gene cluster (results not shown) showed that all the strains share the 265 
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same genes for the maturation of pseudomonic acid A, including the quorum 266 
sensing/quenching system encoded in the gene cluster. 267 
The amount of mupirocin produced in the culture supernatant was between 1-15 µg/ml 268 
depending of the producing strain; P. fluorescens LMG 14677 and W15Feb34 produced 269 
similar amounts, 6.7 and 5.8 µg/ml respectively, as P. fluorescens NCIMB 10586 (8.3 µg/ml). 270 
B329 produced about half of the amount (4.5 µg/ml) of NCIMB 10586. Relatively low 271 
concentrations were detected for W2Jun17 which produced only about 1/10 of the amount 272 
observed for NCIMB 10586 (1.0 µg/ml). W2Aug9 showed the highest level of mupirocin 273 
production, producing twice as much as NCIMB 10586 (15.2 µg/ml). These values are in the 274 
same range as those reported for strains D7 and G11 (1.8-3.5 µg/ml) [7]. The differences in 275 
mupirocin production between the strains were not reflected in their degree of in vitro 276 
antagonism against S. aureus which were similar. The antagonism of NCIMB 10586 and 277 
W2Jun17 showed the lowest level (24.8 ± 0.5 mm and 24.4 ± 0.5 mm, respectively), followed 278 
by LMG 14677 (25.7 ± 1.2 mm), W15Feb34 (26.7 ± 1.0 mm) and W2Aug9 (27.3 ± 1.3 mm). 279 
The largest inhibition zone was observed for B329 (29.0 ± 0.5 mm). The strains showing the 280 
lowest level of antagonism were the strains that do not produce lipopeptides of the 281 
massetolide group, these results indicate that production of massetolide might slightly 282 
increase in vitro antagonism. 283 
 284 
3.2. Identification of mupirocin producing strains 285 
Alignment of the 16S rRNA sequences showed that all the mupirocin producing 286 
strains had identical sequences. Inclusion of the 16S rRNA genes of strain D7 and G11 [7] in 287 
the alignment showed that both strains had also the same 16S rRNA sequence (after 288 
truncating the 5’ and 3’-end by maximum 14 nucleotides to remove evident sequencing 289 
errors) showing that in fact all mupirocin producing strains belong to the same species. 290 
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To identify the strains a phylogenetic tree was constructed based on the 16S rRNA 291 
nucleotide sequence of the selected representative strain P. fluorescens NCIMB 10586 and a 292 
selection of Pseudomonas type strains from the P. fluorescens group. P. fluorescens NCIMB 293 
10586 belongs to the P. fluorescens group and the closest type strain to strain NCIMB 10586 294 
is P. azotoformans IAM 1603 with a bootstrap value of 53% (Fig. 1.A.). The closest relatives 295 
were P. cedrina subsp. cedrina CFML 96-198T, P. cedrina subsp. fulgida DSM 14938T, P. 296 
libanensis CIP 105460T  and P. synxantha IAM 12356T (Fig. 1.A.).  297 
The intraspecific diversity of the mupirocin producing strains was assessed on the 298 
basis of the sequence of the housekeeping gene rpoB. A tree was constructed using the same 299 
methodology as for 16S rRNA. The strains formed a clear separate cluster and a unique rpoB 300 
sequence was found for each strain (Fig. 1.B.).  301 
 302 
3.3. Production of antimicrobial metabolites and protease 303 
The six mupirocin producing strains were screened for additional well-known 304 
antimicrobial metabolites and protease. They were screened by PCR for HCN and the 305 
antibiotics 2,4-diacetylphloroglucinol, pyoluteorin, pyrrolnitrin and phenazine-1-carboxylic 306 
acid. In the conditions used no amplification was obtained for any of these compounds. All 307 
the mupirocin strains produced protease and had similar clear zones around the colony. They 308 
all produced the siderophore pyoverdine. Pyoverdines are made of three distinct structural 309 
parts: a small peptide chain of 6 to 14 L- and D-amino acids, linked to a yellow-green 310 
chromophore group and to a small dicarboxylic acid [24]. Mass analysis showed that all 311 
strains produced the same pyoverdine PYO13525, with a peptide chain of 7 amino acids with 312 
sequence Ser-Lys-Gly-FOHOrn-(Lys-FOHOrn-Ser), the parentheses indicate a cyclic 313 
structure [25]. This pyoverdine is relatively common and is produced by many strains of the 314 
P. fluorescens group (Matthijs S., unpublished results). 315 
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 316 
3.4. Several mupirocin producing strains produce lipopeptides of the massetolide group 317 
The positive drop collapse test observed for three of the six strains, namely 318 
Pseudomonas sp. W2Aug9, Pseudomonas sp. B329, and Pseudomonas sp. W15Feb34 319 
suggested that those isolates may produce compounds with surface tension reducing activity. 320 
In addition, together with P. fluorescens LMG 14677, they displayed hemolytic activity when 321 
tested on red sheep blood cells. Strain W2Aug9 had the largest activity followed by 322 
Pseudomonas sp. B329, P. fluorescens LMG 14677 and Pseudomonas sp. W15Feb34. Those 323 
phenotypes prompted us to check for possible production of surfactants by these strains. 324 
UPLC-MS analysis of culture supernatants revealed that strains W2Aug9, B329, LMG 14677 325 
and W15Feb34 but not NCIMB 10586 and W2Jun17 secreted cyclic lipopeptides with major 326 
peaks observed at m/z 1126.7, 1140.7, 1154.7, 1168.7 for molecular ions (Fig. 2, 327 
Supplementary Fig. S3). These molecular ions correspond to the massetolide group of 328 
Pseudomonas lipopeptides and similar masses and retention times were observed by injecting 329 
purified massetolides from P. fluorescens SS101 [26, 27, 28]. Further analysis of product ions 330 
yielded upon in-source fragmentation of those molecular species confirmed that they 331 
correspond to massetolides A/D, L and F/viscosin with either C10 or C12 fatty acid moieties. 332 
Minor peaks observed at 1152.7 and 1166.7 correspond probably to one unsaturation in the 333 
fatty acid. The occurrence of several derivatives of the lipopeptide reflects some flexibility in 334 
amino acid selection and activation by the A domains of the massetolide synthetases.  335 
When comparing the level of in vitro antagonism of the mupirocin producing strains 336 
on the different media against S. aureus it was observed that strains producing lipopeptides 337 
generally showed a weak, but reproducible, larger zone of inhibition in the antagonism against 338 
S. aureus then strains not producing lipopeptides. To verify whether there was a synergistic 339 
effect a hemolytic-negative mutant was created in strain W2Aug9 which showed the largest 340 
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hemolytic activity. Therefore a Tn5 bank of W2Aug9 was screened for complete loss of 341 
hemolytic activity on blood agar. In total 14 hemolytic-negative candidates were obtained. All 342 
the candidates were negative in a drop collapse test showing loss of surfactant production. 343 
Mutant W2Aug9-F1 was selected from these mutants because it was the only strain that 344 
produced similar clear zones on skim milk plates as the wild type. Sequencing and BlastX 345 
analysis of the Tn5 flanking region of mutant W2Aug9-F1 showed that it had an insertion into 346 
a sequence which showed the highest similarity to massA of Pseudomonas fluorescens SS101 347 
(92% identity at aa level of a 633 bp fragment). The non-ribosomal peptide synthetase 348 
enzyme MassA is responsible for the biosynthesis of the first 2 amino acids of the cyclic 349 
lipopeptide massetolide [27]. In strain P. fluorescens SS101 the massA gene is organized in a 350 
separate cluster from massB and massC. 351 
When tested for in vitro antagonism against S. aureus the massetolide-negative mutant 352 
showed a similar level of antagonism as the wild type Pseudomonas sp. W2Aug9 on all media 353 
tested (results not shown) therefore ruling out a synergistic role for the lipopeptides in the in 354 
vitro antagonism against Staphylococcus. 355 
 356 
3.5. Loss of mupirocin results in pyoverdine-dependent in vitro antagonism 357 
The mupirocin producing strains were strongly antagonistic against S. aureus 383 on 358 
the rich media tested (853, MH and blood agar). The level of in vitro antagonism of the six 359 
strains was comparable (data not shown) and results are detailed only for P. fluorescens 360 
NCIMB 10586 (Fig. 3 and Fig. 4A-D-G). The largest inhibition zone (radius of the zone) for 361 
NCIMB 10586 was observed on 853 (23.3 ± 1.3 mm) (Fig. 4A), followed by MH (20.2 ± 1.5 362 
mm) (Fig. 4D) and blood agar (16.3 ± 0.5 mm) (Fig. 4G). The mupirocin-negative mutant 363 
10586∆AT2 (Fig. 3), completely lost its ability to inhibit S. aureus on blood agar (Fig. 4H). 364 
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On 853 and MH medium the antagonism was strongly reduced (7.5 ± 1.3 mm) and (5.2 ± 0.8 365 
mm), respectively (Fig. 4E and B).  366 
To identify the nature of the compound responsible for the in vitro antagonism of the 367 
mupirocin-negative mutant 10586∆AT2 on 853 (Fig. 4B) a Tn5 mutagenesis was carried out 368 
and the library was screened for transconjugants that completely had lost the antagonism. 369 
Several mutants were obtained and molecular characterization showed that in all these 370 
mutants the Tn5 insertions were in the NRPS genes of pyoverdine. As expected, pyoverdine 371 
was no longer produced in the mutants, strongly suggesting that pyoverdine is responsible for 372 
the antagonism of the mupirocin-negative mutant on medium 853. Mutant 10586∆AT2-373 
10H10 was selected, this mutant had a Tn5 insertion in the middle of the pvdI gene and the 374 
translated sequence of the flanking region of the transposon showed the highest similarity to 375 
PvdI of P. synxantha BG33R (98% identity at aa level of a 800 bp fragment). The in vitro 376 
antagonism of this mutant was tested on 853, MH and blood agar (Fig. 3). On blood agar the 377 
antagonism was completely lost (Fig. 4I), on 853 (Fig. 4C) and MH agar (Fig. 4F) an 378 
inhibition zone was still observed but it was almost completely covered with S. aureus. Since 379 
pyoverdine was responsible for the observed in vitro antagonism the antagonism was also 380 
tested on the low iron media GCA and GCA amended with excess iron. On GCA and 381 
GCA+Fe medium the wild type showed a clear inhibition zone (Fig. 4J and 4M). The 382 
mupirocin-negative mutant showed a clear inhibition zone on GCA (Fig. 4K), this antagonism 383 
was the largest observed on all the media tested for this mutant (Fig. 3). With the addition of 384 
iron the antagonism was completely lost confirming that an iron regulated compound is being 385 
produced (Fig. 4N). The double mupirocin/pyoverdine-negative mutant 10586∆dAT2-10H10 386 
(Fig. 3) showed an inhibition zone into which S. aureus was growing (Fig. 4L) on GCA 387 
medium, as for the mupirocin-negative mutant the antagonism was completely lost in the 388 
presence of iron (Fig. 4O). 389 
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To look at the effect of the loss of only pyoverdine on the antagonism against S. 390 
aureus, a pyoverdine-negative mutant, 10586-3H3, was obtained through Tn5 mutagenesis of 391 
the wild type NCIMB 10586. This mutant had an insertion into a gene of which the translated 392 
sequence had the highest similarity to PvdD of P. synxantha BG33R (98% identity at aa level 393 
of a 748 bp fragment). The pvdD mutant was not affected in the in vitro antagonism against S. 394 
aureus on any of the media tested (Fig. 3). The growth inhibition effect due to pyoverdine 395 
appeared to be masked by mupirocin for this strain.  396 
 397 
4. Conclusion 398 
The polyketide mupirocin is a valuable antibiotic, with a current therapeutic use. Until 399 
now it has only been produced from P. fluorescens NCIMB 10586 where its synthesis is 400 
encoded by a 65-kb long region comprising 35 genes [12, 29]. In this work, five new 401 
mupirocin producing strains were identified during the screening of a phylogenetically diverse 402 
collection of 578 Pseudomonas strains and isolates. Together with the two reported mupirocin 403 
producing strains D7 and G11 [7], they all belong to the same species as P. fluorescens 404 
NCIMB 10586. Accordingly, mupirocin production seems to be restricted to a limited number 405 
of isolates belonging to one single species which is different from the currently published 406 
Pseudomonas type strains.  407 
One explanation for the apparent unique phylogenetic affiliation of the mupirocin 408 
producing strains would result from the methodology used to detect mupirocin producing 409 
isolates. Indeed, when screening for a specific gene by PCR, candidates may be missed 410 
because one or both primers do not anneal due to sequence divergence at the primer annealing 411 
site. Yet, the mupirocin producing strains D7 and G11 were isolated on the basis of the 412 
antimicrobial effect of their supernatant on Gram-positive bacteria and not by PCR. The fact 413 
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that mupirocin producing strains isolated using 2 different approaches all belong to the same 414 
species supports that mupirocin is probably produced by a restricted group of strains. 415 
The capacity to produce mupirocin could well have been acquired by horizontal gene 416 
transfer in a recent ancestor of the species. Indeed, analysis of the flanking region of the 417 
mupirocin gene cluster suggests that the cluster may be an insertion integrated by 418 
recombination at tRNA genes as observed for a number of phage and mobile elements [12]. 419 
Interestingly, the antibiotic thiomarinol produced by the marine bacterium 420 
Pseudoalteromonas sp. SANK 73390 is a hybrid of two components: pseudomonic acid and 421 
pyrrothine [30; 31]. Both compounds are encoded by 2 different clusters on plasmid pTML1 422 
[30]. 423 
Mupirocin has a broad spectrum activity and the acquisition of the mupirocin gene 424 
cluster may significantly increase fitness and competitiveness of the species. Yet as a 425 
consequence of the small number of mupirocin producing strains some uncertainty remains 426 
with respect to the true ecology of the species and its way of life. 427 
In our collection and in the study of [7], mupirocin producing strains were 428 
predominantly isolated from water and soil environments. Only one strain, Pseudomonas sp. 429 
B329, was isolated from the rhizosphere of grass. Interestingly, this was the only strain of the 430 
six mupirocin producing strains which showed motility under microscope (results not shown). 431 
Yet, rhizosphere strains are underrepresented in the collection screened; this could explain 432 
why only one rhizosphere strain was picked up during the screening.  433 
Given the strong antimicrobial activity of mupirocin it would be interesting to test 434 
these strains as biocontrol agents against bacterial disease. The ability of some of the 435 
mupirocin producing strains to produce lipopeptides of the massetolide group, which have 436 
surfactant and antimicrobial properties, could potentially even make the strains active against 437 
fungal diseases [32]. 438 
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Table 1. List of strains used in this study. 
Strain Relevant genotype/characteristics Reference  
Pseudomonas fluorescens 
NCIMB 10586 
Mupirocin producing strain isolated 
from soil, Hampstead Heath, London, 
U.K. 
[1] 
10586∆AT2 Mupirocin-negative deletion 
(MmpC∆337-548) mutant of P. 
fluorescens NCIMB 10586 
[12] 
10586-3H3 Pyoverdine-negative Tn5 mutant of P. 
fluorescens NCIMB 10586 with a Tn5 
insertion into the pvdD gene, GmR 
This study 
10586∆AT2-10H10 Pyoverdine-negative mutant of 
10586∆AT2 with a Tn5 insertion into 
the pvdI gene, GmR 
This study 
Pseudomonas fluorescens 
LMG 14677 
Mupirocin producing strain [33] 
Pseudomonas sp. W2Aug9 Mupirocin producing strain isolated 
from river water, Brussels, Belgium 
[8] 
W2Aug9-F1 Massetolide-negative Tn5 mutant of 
Pseudomonas sp. W2Aug9 with a Tn5 
insertion into massA, GmR 
This study 
Pseudomonas sp. B329 Mupirocin producing strain isolated 
from rhizosphere of grass, France 
Bodilis J., France 
Pseudomonas sp. W2Jun17 Mupirocin producing strain isolated 
from river water, Brussels, Belgium 
[8] 
Pseudomonas sp. W15Feb34 Mupirocin producing strain isolated 
from river water, Brussels, Belgium 
[8] 
Staphylococcus aureus 383 Clinical strain isolated from infected 
femoral pin, mupirocin-sensitive 
[21] 
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Fig. 1.A. Phylogenetic relationships among 21 Pseudomonas type strains of the P. fluorescens 
group and P. fluorescens NCIMB 10586 based on 16S rRNA sequences (the accession 
number of the 16S rRNA sequences are indicated after the strain name). P. aeruginosa LMG 
1242
T
 was used as outgroup to root the tree. The tree was constructed using the NJ method. 
Number at nodes represents levels (%) of bootstrap support from 1000 resampled datasets. 
The bar represents 0.01 substitutions per nucleotide position.  
Fig. 1.A. 
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Fig. 1.B. Phylogenetic relationships among the mupirocin producing strains based on rpoB 
gene sequences (the accession number of the rpoB gene sequences are indicated after the 
strain name). P. aeruginosa LMG 1242
T
 was used as outgroup to root the tree. The strains 
with hemolytic activity are indicated by a black dot. The tree was constructed using the NJ 
method. Number at nodes represents levels (%) of bootstrap support from 1000 resampled 
datasets. The bar represents 0.01 substitutions per nucleotide position. 
 
 
 
Fig. 1.B. 
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Fig 2. UPLC-MS analysis of culture supernatants of Pseudomonas sp. W2Aug9. Strain 
W2Aug9 secretes cyclic lipopeptides with major peaks observed at m/z 1126.7, 1140.7, 
1154.7 and 1168.7 for molecular ions. Further analysis of product ions yielded upon in-source 
fragmentation of those molecular species confirmed that they correspond to massetolides 
A/D, L and F/viscosin with either C10 or C12 fatty acid moieties. Minor peaks observed at 
1152.7 and 1166.7 correspond probably to one unsaturation in the fatty acid. 
 
 
 
Fig. 2. 
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Fig. 3. The in vitro antagonism of the wild type P. fluorescens NCIMB 10586, the mupirocin-
negative mutant 10586∆AT2, the pyoverdine-negative mutant 10586-3H3 and the double 
mupirocin/pyoverdine-negative mutant 10586∆AT2-10H10. The bars represent the inhibition 
zone (mm) observed against S. aureus 383. For the double mutant the color of the bar is 
presented as a gradient since inhibition zones were observed which were partially covered 
with bacteria.  
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Fig. 4. Comparison of the in vitro antagonism of P. fluorescens NCIMB 10586 (first column), 
the mupirocin-negative mutant 10586∆AT2 (second column) and the double 
mupirocin/pyoverdine-negative mutant 10586∆AT2-10H10 (last column) against S. aureus 
383 on 853 agar (A-C), MH agar (D-F), blood agar (G-I), GCA (J-L) and GCA+Fe medium 
(M-O).  
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Supplementary Table S1. List of Pseudomonas type strains obtained from ATCC (American Type Culture Collection, US), BCCM/LMG 
Culture Collection (Belgium), CCUG (Culture Collection, University of Göteborg, Sweden), CFBP (French Collection of Plant associated 
bacteria, France), CFML (Collection de la Faculté de Médecine de Lille, France), CIP (Collection de l’Institut Pasteur, France) and DSMZ 
(Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Germany). 
Species Strain Biological origin Geographic origin 
P. abietaniphila CIP 106708T Aerated lagoon of bleached kraft pulp mill 
effluent 
Kamploops British Columbia 
Canada 
P. aeruginosa ATCC 10145T     
P. agarici CFBP 2063T Mushroom (Agaricus bisporus) New Zealand 
P. alcaliphila CCUG 136T Seawater  Near the coast of Rumoi, Hokkaido, 
Japan 
P. amygdali DSM 7298T Almond, Prunus dulcis Greece 
P. anguilliseptica CCUG 35503T Pond-cultured eels (Anguilla japonica) Japan 
P. antarctica CIP 108466T Cyanobacterial mat Pond L3 Wright Valley Adam's 
glacier stream 1 Antarctica 
P. argentinensis CIP 108775T Chloris ciliata, rhizopshere Cordoba, Argentina 
P. arsenicoxydans CCUG 58201T Sediment Chile, Atacama Desert, Camarones 
Valley 
P. asplenii ATCC 23835T Asplenium nidus   
P. avellanae CIP 105176T Hazelnut (Corylus avellanea) Greece 
P. azotifigens DSM 17556T Compost pile Japan:Okinawa, Nakijin 
P. azotoformans DSM 18862T Paddies Japan 
P. baetica LMG 25716T Diseased Dicologoglossa cuneata   
P. balearica DSM 6083T Wastewater treatment plant Mallorca, Spain 
P. bauzanensis LMG 26048T Soil contaminated with hydrocarbon and 
heavy metal from an industrial site 
Italy, South Tyrol, Bozen 
P. benzenivorans DSM 8628T Soil and groundwater contaminated with 
chlorobenzene 
USA, Gulf Coast 
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P. brassicacearum subsp. 
brassicacearum 
DBK11T Rhizoplane of Brassica napus Dieulouard, France 
P. brassicacearum subsp. 
neoaurantiaca  
CIP 109457T Rhizophere of hemp plants Ukraine, near Kiev 
P. brenneri DSM 15294T French natural mineral water after bottling Lille, France 
P. caricapapayae CFBP 3204T Carica papaya Brazil 
P. cedrina subsp. cedrina LMG 23661T Spring water Lebanon 
P. cedrina subsp. fulgida DSM 14938T Phyllosphere of grasses Paulinenaue, Germany 
P. chlororaphis subsp. aurantiaca ATCC 33663T   
P. chlororaphis subsp. aureofaciens LMG 1245T Maas River clay suspended in kerosene for 
three weeks 
Netherlands 
P. chlororaphis subsp. chlororaphis ATCC 9446T Plate contaminant  
P. cichorii CFBP 2101T Cichorium endivia Germany 
P. citronellolis CFBP 5585T Soil under pine trees   
P. composti DSM 25648T Mixed vegetables and animal waste compost   
P. congelans CFBP 7019T Phyllosphere of grasses Germany 
P. costantinii CFBP 5705T Agaricus bisporus Finland 
P. corrugata LMG 2172T Lycopersicon esculentum (tomato) pith 
necrosis 
United Kingdom 
P. cremoricolorata DSM 17059T Oryza sativa Japan 
P. cuatrocienegasensis LMG 24676T Water (evaporating lagoon) Cuatro Ciénegas, Coahuila state, 
Mexico 
P. deceptionensis LMG 25555T Marine sediment Deception Island, South Shetland 
Islands, Antarctica 
P. delhiensis  DSM 18900T Soil sample contaminated by polycylic 
aromatic compounds of fly ash dumping site 
India 
P. duriflava DSM 21419T Desert soil Xinjiang Province, China 
P. entomophila L48T Drosophila Calvaire, Guadeloupe, France 
P. extremaustralis  DSM 17835T Temporary water pond Danco Coast, Cierva Point, 
Antarctica 
P. extremorientalis CCUG 51517T Drinking water reservoir Vladivostock City, Russia 
P. ficuserectae CCUG 32779T Ficus erectae  
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P. flavescens CFBP 5586T Canker tissue of Juglans regia California 
P. fluorescens ATCC 13525T Pre-filter tanks UK 
P. fragi ATCC 4973T   
P. fulva DSM 17717T Rice paddy Japan 
P. fuscovaginae CFBP 2801T Oriza sativa  
P. gessardii CFML 95-251T Mineral water  France  
P. graminis CCUG 51504T Surface plant material from a mixed meadow  Germany 
P. grimontii DSM 17515T Mineral water  France  
P. guariconensis LMG 27394T   
P. guineae CFBP 7180T Soil Deception Island (South Shetland 
Islands), Antarctica 
P. helmanticensis LMG 28168T Forest soil Salamanca, Spain 
P. japonica CCUG 59367T Activated sludge from sewage treatment plant Adachi-ku, Odaii, Tokyo, Japan 
P. jessenii CFML 95-307T Mineral water  France  
P. jinjuensis DSM 16612T Agricultural soil Korea 
P. kilonensis DSM 13647T Agricultural soil Germany 
P. knackmussii DSM 6978T Sewage plant Germany 
P. koreensis CCUG 51519T Agricultural soil Korea 
P. kuykendallii LMG 26364T Bioreactor that degrade the herbicide 
hexazinone, inoculated with soil 
Wiggins, Colorado, USA 
P. libanensis CFML 96-
195TT 
Spring water Lebanon 
P. lini D-LE411JT Bulk and rhizospheric soil Dijon, France 
P. lundensis DSM 6252T Prepacked beef Sweden 
P. lurida CCUG 54630T Phyllosphere of grasses Germany 
P. lutea DSM 17257T Soil Spain 
P. luteola CIP 102995T Human wound   
P. mandelii CFML 95-303T Mineral water  France 
P. marginalis ATCC 10844T Cichorium intybus imported from Belgium USA 
P. marincola LMG 24752T Deep-sea brittle star Fiji, at a depth of 480 m 
P. mediterranea CFBP 5447T Pith necrosis on tomato plant Italy 
P. mendocina ATCC 25411T Soil, enrichment with ethanol  
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P. mohnii CCUG 53115T Sequencing batch reactor treating paper mill 
effluent, enrichment with isopimaric acid 
Canada 
P. monteilii DSM 14164T Human bronchial aspirate France 
P. moorei DSM 12647T Soil samples   
P. moraviensis DSM 16007T Soil besides highway Czech Republic 
P. mosselii ATCC BAA-
99T 
Medical specimen France 
P. mucidolens CCUG 1424T Musty egg   
P. nitroreducens ATCC 33634T Oil-brine Japan 
P. oleovorans subsp. oleovorans CFBP 5589T Cutting fluid 
 
 
P. oleovorans subsp. lubricantis DSM 21016T Contaminated metalworking fluids Houghton, Michigan, USA 
P. orientalis DSM 17489T Spring water Lebanon 
P. otitidis DSM 17224T Ear of patient with acute Otitis externa USA 
P. palleroniana CFBP 4389T Oryza sativa Cameroon 
P. panacis DSM 18529T Rusty root lesions of Korean ginseng South Korea 
P. panipatensis LMG 24738T Oil contaminated soil Panipat Oil Refinery, India 
P. parafulva DSM 117004T Oryza sativa Japan 
P. peli CIP 109374T Antarctic green alga Pyramimonas gelidicola Antarctica 
P. plecoglossicida CIP 106493T Diseased ayu, Plecoglossus altevelis Japan 
P. poae CFBP 6764T Grasses, phyllopshere Paulinenaue, Brandenburg, 
Germany 
P. pohangensis DSM 17875T Sea shore sand Korea 
P. prosekii LMG 26867T Rock biofilm James Ross Island, Waterfall, west 
side of Lachmen Crags Antarctica 
P. protegens CHA0T Soil suppressing black root rot of tobacco 
(Nicotiana glutinosa) 
Switzerland 
P. proteolytica CIP 108464T Cyanobacterial mat samples Antarctica 
P. putida CFBP 2066T Soil, lactate enrichment United States 
P. reinekei CCUG 53116T Aerobic zone of Elbe sediment enriched with 
4-chlorosalicylate 
Germany 
P. resinovorans CCUG 2473T Soil France, Vienne 
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P. rhodesiae ATCC 17764T Natural mineral water France 
P. sabulinigri DSM 23971T Black sand originating from black volcanic 
basalt rock 
Jeju Island, Soesgoggak, Korea 
P. salomonii CFBP 2022T Allium sativum France 
P. saponiphila DSM 9751T   Michigan, USA 
P. savastanoi CIP 103721T Olea europaea Yugoslavia 
P. segetis CCUG 54777T Soil Korea 
P. simiae  DSM 18861T Lung of female monkey (Callithrix geoffroyi) 
with pneumonitis and pneumonia 
Spain 
P. straminea CCUG 12539T Japanese unhulled rice Japan 
P. stutzeri ATCC 17588T Spinal fluid  
P. synxantha DSM 18928T Cream Iowa, USA 
P. syringae subsp. syringae ATCC 19310T Syringa vulgaris United Kingdom 
P. taetrolens CCUG 560T Musty egg  
P. taiwanensis DSM 21245T Soil Tamkang University, Taipei, Taiwan 
P. thivervalensis CFBP 5754T Rhizoplane of Brassica napus Sexy-les-Bois, France 
P. tolaasii CFBP 2068T Agaricus bisporus United Kingdom 
P. trivialis CFBP 6765T Grasses, phyllopshere Paulinenaue, Brandenburg, 
Germany 
P. umsongensis CIP 108618T Agricultural soil Korea 
P. vancouverensis ATCC 
700688T 
Forest soil Canada 
P. veronii CFML 92-134T Mineral water France 
P. viridiflava ATCC 13223T Dwarf or runner bean Switzerland 
P. vranovensis DSM 16006T Soil besides highway Czech Republic 
P. xiamenensis  DSM 22326T Activated sludge sample collected at Qianpu 
sewage treatment plant 
Fujian, Xiamen, China 
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Supplementary Table S2. List of Pseudomonas non type strains obtained from ATCC (American Type Culture Collection, US), BCCM/LMG 
Culture Collection (Belgium), CFBP (French Collection of Plant associated bacteria, France), CFML (Collection de la Faculté de Médecine de 
Lille, France), DSMZ (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Germany). 
Strain  Species  Biological origin Geographic origin 
ATCC 17400 P. fluorescens Egg yolk  
ATCC 39167 P. putida   
ATCC 43928 P. chlororaphis Agricultural field Denmark 
CFBP 2123 P. fluorescens Tap water Netherlands 
CFBP 2124 P. fluorescens Lactate-enriched water  
CFBP 2125 P. fluorescens Enrichment with naphthalene  
CFBP 2129 P. fluorescens Hydrocarbon enrichment Berkeley, United States 
CFBP 2131 P. fluorescens Soil  
CFBP 2392  Rhizosphere of Phaseolus vulgaris France 
CFBP 2461 P. putida Soil France 
CFBP 3140 P. putida   
CFBP 3142 P. putida Soil  
CFBP 3143 P. putida Soil  
CFBP 3150 P. fluorescens Soil  
CFBP 3153 P. marginalis pv. marginalis Pleural fluid  
CFBP 3155 P. chlororaphis Farm soil Peoria, USA 
CFBP 4628  P. putida Lycopersicon esculentum Maine et Loire Angers, France 
CFBP 4966  P. putida Lycopersicon esculentum Guadeloupe, France 
CFBP 4967  P. fluorescens  Lycopersicon esculentum Guadeloupe, France 
CFBP 4970  P. putida Lycopersicon esculentum Guadeloupe, France 
CFBP 4971  P. putida Lycopersicon esculentum Guadeloupe, France 
CFBP 4976  Pseudomonas sp. Tabac Maine et Loire Angers, France 
CFBP 5891  P. putida Zea mays Maine et Loire, France 
CFBP 5898 P. putida Zea mays Maine et Loire, France 
CFBP 5913 P. putida Zea mays Maine et Loire, France 
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CFBP 5921  P. putida Lycopersicon esculentum Guadeloupe, France 
CFBP 5930  P. putida Lycopersicon esculentum Angers, France 
CFBP 5933  P. putida Lycopersicon esculentum Angers, France 
CFML 90-33 P. putida   
CFML 90-40 P. putida   
CFML 90-42 P. putida   
CFML 90-44 P. putida   
CFML 90-51 P. putida Clinical  
CFML 90-136 P. putida   
CFML 95-275 Pseudomonas sp.   
CFML 96-132 Pseudomonas sp.   
CFML 96-188 Pseudomonas sp. Spring water (Kadicha) Lebanon 
CFML 96-312 Pseudomonas sp.   
CFML 96-318 Pseudomonas sp.   
CFML 96-319 Pseudomonas sp.   
DSM 3602 P. stutzeri Black earth soil Gatton, Queensland, Australia 
DSM 50106 P. fluorescens Seawater  
LMG 1244 P. fluorescens Polluted seawater Dresund, Denmark 
LMG 14576 P. fluorescens Well water  
LMG 14677 P. fluorescens   
LMG 2189 P. fluorescens   
LMG 5831 P. fluorescens Polluted natural stream South Copenhagen, Denmark 
LMG 5848 P. fluorescens Cichorium intybus, leaves showing 
blackening of vascular system 
United Kingdom 
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Supplementary Table S3. List of Pseudomonas strains and isolates obtained from different laboratories and their biological and geographic 
origin. 
Pseudomonas strains and isolates Biological and geographic origin Reference 
LUBF-l55, LUBF-l59, LUBF-l69, LUBF-l88, LUBF-l102, 
LUBF-l104, LUBF-l107, LUBF-l112, LUBF-l212, LUBF-l410, 
LUBF-l615, LUBF-l715 
 
Spoilage of Sparus aurata stored under 
various conditions 
[1] 
SWPA 6, SWPA 40A, SWPA 40B, SWPA 36A, SWPA 36B, 
SWPA 36C, SWPA 10.20A, SWPA 10.20B, SWPA 10.20C, 
115 thio, 120, LS2-01, 545, 415, 250A, 250B, 250C, 250D, 
SWPA0004-10, SW4, SW5, SW6, SW7, SW33, SW11, SW16, 
SW29, SWPA 115 25-F, SWPA 820 18-F, SWPA 2404 25-T 
 
TKM iso1, TKM iso2, TKC, LKA, TKD1, 4T, 5TWPS, 
3TWPS, TW1, 2T  
 
Br232, Br252 
 
 
 
Br996 
 
Mex8A, Mex8B1, Mex8C1, Mex8D1 
Seawater, North Sea (few km before the 
coast, 15m depth) 
 
 
 
 
Lake Tanganyika  
 
 
Unfiltered tap water, Burn Centre, 
Queen Astrid Military Hospital, 
Brussels, Belgium 
 
Water tank of a ship 
 
Water of a cenote, Loltun, Mexico 
Jean-Paul Pirnay, Belgium 
(unpublished) 
 
 
 
 
Jean-Paul Pirnay, Belgium 
(unpublished) 
 
Jean-Paul Pirnay, Belgium 
(unpublished) 
 
 
Jean-Paul Pirnay, Belgium 
(unpublished) 
Jean-Paul Pirnay, Belgium 
(unpublished) 
K-SR5, K-SR6, K-SR7, K-SR8, K-SR9, K-SR10, K-SR11, K-
SR21, K-SR33 
Rhizosphere Salsola vermiculata, 
Bèchar, Algeria 
Khadidja Chafi, Algeria 
(unpublished) 
 
MFY0 
 
MFY30, MFY31, MFY32, MFY33, MFY52, MFY76, MFY80, 
 
Raw milk 
 
Bulk soil 
 
[2] 
 
[2] 
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MFY81, MFY122, MFY140, MFY152, MFY160, MFY138, 
MFY143, MFY146, MFY220, MFY338, MFY245 
 
OE28.3 
 
MFY59, MFY63, 
 
MFY57, MFY68, MFY163 
 
MFY161 
 
MFY78, MFY79 
 
MFY70 
 
MFY65 
 
MFY61 
 
MFY162 
 
MFY69 
 
MFY71 
 
 
 
Rhizosphere  
 
Urine, Pitié Salpêtrière Hospital, France  
 
Blood, Pitié Salpêtrière Hospital, France 
 
Blood/urine, Charles Nicolle Hospital, 
France 
Dun River, France 
 
Suppuration, Pitié Salpêtrière Hospital, 
France  
Infected sinus 
 
Articular infection 
 
Sputtum, Charles Nicolle Hospital, 
France 
Gastric fluid, Pitié Salpêtrière Hospital, 
France 
Clinical  
 
 
 
[2] 
 
[2] 
 
[2] 
 
[2] 
 
[2] 
 
[2] 
 
[2] 
 
[2] 
 
[2] 
 
[2] 
 
[2] 
 
R2f, B13, B125, B136, B163, B215, B329 Rhizosphere 
 
Josselin Bodilis, France 
(unpublished) 
R-35697, R-35701, R-35703, R-35705, R-35706, R-35709, R-
35710, R-35717, R-35719, R-35702, R-35711, R-35721, R-
35723, R-35724, R-35708, R-35700, R-35720, R-35707, R-
35725 
 
Milk, Belgium [3] 
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PD4, PD5, PD11, PD13, PD15, PD22, PD28, PD31 Arable soil used for potato production, 
New Brunswick, Canada 
[4] 
P. putida BTP1, P. fluorescens BTP2, BTP7', BTP9, BTP14, 
PP, P. putida PutC 
 
 Collection obtained from 
Marc Ongena, Belgium 
P. putida Irc204 Soil, Belgium IRMW 
 
P. fluorescens E211, P. kilonensis/brassicacearum G11, P. 
fluorescens G27 
 
Rhizosphere of Echinochloa crus-
galli/Galium mollugo 
[5] 
P. putida WCS358, WCS365, P. fluorescens WCS374 
 
  
Pseudomonas sp. B10, P. fluorescens G153, P. fluorescens 
G166, P. fluorescens G173, P. chlororaphis D-TR133, P. 
putida G4R, P. fluorescens 99-13, P. fluorescens PL7, P. 
fluorescens PL8, P. fluorescens PL9, Pseudomonas sp. D46, 
Pseudomonas sp. D47, P. fluorescens Pflii, P. fluorescens 
Pfl12, P. fluorescens PflW, Pseudomonas sp. F360, P. 
fluorescens 9AW, P. fluorescens 1547, SB8.3, Pseudomonas 
sp. 2908, P. fluorescens 1.3, P. fluorescens 18.1, HR6, P. 
monteilii Lille 1, P. fluorescens 51W, P. rhodesiae Lille 25, 
Gwose, Pseudomonas sp. A214, P. fluorescens A225, P. putida 
Thai, P. aeruginosa R', Pseudomonas sp. 6-10, LBSA1, IB3, 
7SR1, ML35, Malar, P. aeruginosa Pa6, Lille 17, Pseudomonas 
sp., Pseudomonas sp. F317, P. fuscovaginae G17, 
Pseudomonas sp. G400 
 
 Collection obtained from 
Jean-Marie Meyer, France 
P. putida GM 10090 (G297), P. putida GM 11799.1 (G309), P. 
putida GM 12220 (G314)  
 
Plant rhizosphere 
 
[6] 
P. putida GS4 (GS12059), P. putida GS35 (GS12082), P. 
putida GS37 (GS12064) 
Plant rhizosphere (banana tree) [7] 
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SR11, SR14, SR18, SR28, SR44, SR45, SR54, SR56, SR64, 
SR66, SR67, SR68, SR70 
 
Metal-contaminated sediment [8] 
P. brassicacearum R1-4 
 
Rhizosphere oilseed rape [9] 
P. thivervalensis DR5, P. brassicacearum BGCR2-9(1) Bacterial endophyte from field-grown 
Solanum nigrum 
[10] 
AF76 Rhizosphere ground nut (Arachis 
hypogaea L.), India 
[11] 
[1] Tryfinopoulou P, Tsakalidou E, Nychas G-JE, Characterization of Pseudomonas spp. associated with spoilage of gilt-head sea bream stored 
under various conditions, Appl Environ Microbiol 68 (2002) 65-72. 
[2] Chevalier S, Bodilis J, Jaouen T, Barray S, Feuilloley MGJ, Orange N, Sequence diversity of the OprD protein of environmental 
Pseudomonas strains, Environ Microbiol 9 (2007) 824-835. 
[3] Marchand S, Heylen K, Messens W, Coudijzer K, De Vos P, Dewettinck K, Herman L, De Block J, Heyndrickx M, Seasonal influence on 
heat-resistant proteolytic capacity of Pseudomonas lundensis and Pseudomonas fragi, predominant milk spoilers isolated from Belgian 
raw milk samples, Environ Microbiol 11 (2009) 467-482. 
[4] Dandie CE, Burton DL, Zebarth BJ, Trevors JT, Goyer C, Analysis of denitrification genes and comparison of nosZ, cnorB and 16S rDNA 
from culturable denitrifying bacteria in potato cropping systems, Syst Appl Microbiol 30 (2007) 128-138. 
[5] Zeller SL, Brandl H, Schmid B, Host-plant selectivity of rhizobacteria in a crop/weed model system, PloS ONE 2(9): e846.  
[6] Mattar J, Les Pseudomonas fluorescents de la rhizosphère: caractérisation, incidence de la température et de la microflore autochtone sur la 
colonisation racinaire, p. 87. PhD thesis, Université de Lyon I, France (1993). 
[7] Sutra L, Risède JM, Gardan L, Isolation of fluorescent pseudomonads from the rhizosphere of banana plants antagonistic towards root 
necrosing fungi, Lett Appl Microbiol 31 (2000) 289-293. 
[8] Roosa S, Vander Wauven C, Billon G, Matthijs S, Wattiez R, Gillan DC, The Pseudomonas community in metal-contaminated sediments as 
revealed by quantitative PCR: a link with bioavailability. Res Microbiol (2014) 10.1016/j.resmic.2014.07.011. 
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[9] Gasser I, Müller H, Berg G, Ecology and characterization of polyhydroxyalkanoate-producing microorganisms on and in plants, FEMS 
Microbiol Ecol 70 (2009) 142-150. 
[10] Long HH, Sonntag DG, Schmidt DD, Baldwin IT, The structure of the culturable root bacterial endophyte community of Nicotiana 
attenuata is organized by soil composition and host plant ethylene production and perception, New Phytologist 185 (2010) 554–567.  
[11] Matthijs S, Budzikiewicz H, Schäfer M, Wathelet B, Cornelis P, Ornicorrugatin, a new siderophore from Pseudomonas fluorescens AF76, Z 
Naturforsch 63c (2008) 8-12. 
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Supplementary Table S4. Primers and their sequences used to amplify part of the tailoring genes of the mupirocin gene cluster. 
  
Primer Sequence 5’-3’ Size amplicon Primer Sequence 5’-3’ Size amplicon 
mupZ-F ATGAATCGCACCTGCATGGC  mupL-F ATGCAACTGATCACGCACGA  
mupZ-R GAACTGCGGCITCATAAACG 324 bp mupL-R ATCCACGTCTGCCTCACCCT 936 bp 
TEB-F TGACGCTGCTCAATCACGCT  mupM-F ATGAGTACGGAAGGAAGTGG  
TEB-R ACCTGCITGAGGGACACCAC 440 bp mupM-R GCGGATGAACCAGGACTCTA 1221 bp 
mmpC-F GGGTCGCAATACCGTCACAT  mupO-F GACATCGTGGGAAAGAGAGG  
mmpC-R CGTTGAGCGATTTCGACAAT 2140 bp mupO-R GTAGGAGATGATGGCGTGGIT 775 bp 
MetD3-F ATGITCCCCGAGGGTTCCAT  mupP-F GTGAGCAGGTCCGAACTTG  
MetD3-R GCTCAGCTCGITCAACAACA 470 bp mupP-R TCGGTAAAGGGCAITGAAGTG 699 bp 
mupC-F AAGGTCGTCGGGITCACTGG  mupQ-F ATGAGAGAGGAACGTAATTGG  
mupC-R CGGTAAGTGGCTTCGGACAA 531 bp mupQ-R CCTTGAAATCITCCAACCCT 1279 bp 
macpA-F ATGAACCCTGAAAGGCGGAA  mupS-F ATGACTGATGCAGTTTCTGACG  
macpA-R GITGACGGCACTCATCCAIT 222 bp mupS-R TGCGGGTCAAGCCATCC 535 bp 
mupD-F ATGCGTAGGCAGGTAGTCGT  mupT-F ITGGTAGAGCATCCGCCC  
mupD-R GGTGAGATGITGCCCGITGA 708 bp mupT-R TCACGTACCGCACTCCAGCC 351 bp 
mupE-F GGCGCTTCAACTGGTTGATA  mupU-F ATGGAACAGITGACCCCTGG  
mupE-R CCGAAAGAGCCATGAATGTG 864 bp mupU-R GCGACACTACCGCCACIT 1336 bp 
mupF-F TCAGGGTGCTGTCGGGGATA  mupV-F AAAGCTCTATGTGACCGGCG  
mupF-R GGCAGCCATATTGTGGAAAA 969 bp mupV-R GCTGGAITGGCGGCTCT 1630 bp 
mupG-F ATGGCAAGCTCTGACACGCA  mupW-F GCAAATTGATCGAGCACGTC  
mupG-R ACTGCCGTGCGGGTTGATAT 918 bp mupW-R GGCGTGCTCATAGGTGTCG 1208 bp 
mupH-F ATGACGAGGCAAGTGGGTAT  mupX-F TGGTCAGCGCGTTCCACTTT  
mupH-R CCCAGCAGGAITGACTCGTA 1121 bp mupX-R AAGAGTGAGGCGGGCTACG 1510 bp 
mupJ-F ATGAACITCCAGGCCACCGA  mupl-F TAGCATTGACTGCGTCCAGG  
mupJ-R TGGCTGACATAGCGGTGGAT 740 bp mupl-R GAACATATCACCACGITATCTGGA 555 bp 
mupK-F GGACAGTGTCATCGATITTCAGG  mupR-F TGCITGAAGACAITCTGATG  
mupK-R CCAACTCCATCGCCAACTCC 581 bp mupR-R GCCACCCACITCAGACA 550 bp 
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Supplementary Table S5. The interspecies similarity values for the rpoB gene of the mupirocin producing strains. 
Species  1 2 3 4 5 6 
1. P. fluorescens NCIMB 10586 100.0      
2. Pseudomonas sp. W2Aug9  99.13 100.0     
3. Pseudomonas sp. W2Jun17 99.02 99.89 100.0    
4. Pseudomonas sp. W15Feb34 99.02 99.67 99.57 100.0   
5. Pseudomonas sp. B329 99.57 99.35 99.24 99.24 100.0  
6. P. fluorescens LMG 14677 99.89 99.89 99.79 99.79 99.24 100.0 
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Supplementary Fig. S1. Part of the mmpD gene of P. fluorescens NCIMB 10586 that aligns with the complementary sequence of the PltBf and 
PltBr primers. The nucleotides that mismatch are indicated in red. There was only 1 internal nucleotide mismatch with the forward primer and 3 
mismatches of 4 nucleotides (thereby discarding the nucleotide at the 5’end) with the reverse primer. 
 
 
mmpD NCIMB 10586:  5’-CGGATCATGGACCCCCAGC-3’ 
        ׀׀׀׀ ׀׀׀׀׀׀׀׀׀׀׀׀׀׀ 
PltBf primer:   5’-CGGAGCATGGACCCCCAGC-3’ 
 
 
mmpD NCIMB 10586:  5’-ATGGCCGATATTGGATTTGGCCGAG-3’ 
           ׀׀׀ ׀׀׀׀׀׀׀ ׀׀׀׀׀׀׀׀׀׀  
PltBr primer:   5’-GTGCCCGATATTGGTCTTGACCGAG-3’ 
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Supplementary Fig. S2. Identification of main peaks in supernatants of the reference strain P. fluorescens NCIMB 10586, the mupirocin-
negative mutant ∆AT2 and the mupirocin producing strains P. fluorescens LMG 14677 and Pseudomonas sp. W2Jun17, W15Feb34, W2Aug9 
and B329. The peak with retention time (RT) 2.31 is pseudomonic acid B, the peak with RT 2.46 is pseudomonic acid A. 
LMG 14677 
W2Jun17 
W15Feb34 
W2Aug9 
NCIMB 10586 
∆AT2 
B329 
Peak with RT 2,31 
Peak with RT 2,46 
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Supplementary Fig. S3. Fragmentation patterns obtained for the 
main lipopeptide molecular ions in Pseudomonas sp. W2Aug9. 
  
 
 
 
 
Representative ions (m/z) 
 
Fragment species 
 
283,6 C10FA-Leu 
412,6 C10FA-Leu-Glu 
495,6 (-H2O); 513,6 (-2H2O) C10FA-Leu-Glu-Thr 
594,6 (-H2O); 566,6 (-2H2O) C10FA-Leu-Glu-Thr-Val 
608,6 (-H2O); 580,6 (-2H2O) C10FA-Leu-Glu-Thr-Ile/Leu 
186 (204, +H2O) Ser-Val 
200 (218, +H2O) Ser-Ile/Leu 
299 (313, +H2O) Leu-Ser-Val 
313 (331, +H2O) Leu-Ser-Ile/Leu 
386 (404, +H2O) Ser-Leu-Ser-Val 
400 (418, +H2O) Ser-Leu-Ser-Ile/Leu 
499 (517, +H2O) Leu-Ser-Leu-Ser-Val 
513 (531, +H2O) Leu-Ser-Leu-Ser-Ile/Leu 
612 (630, +H2O) Val/Ile/Leu-Leu-Ser-Leu-Ser-Val/Ile/Leu 
695 (713, +H2O) Thr-Val/Ile/Leu-Leu-Ser-Leu-Ser-Val/Ile/Leu 
824 (842, +H2O) Glu-Thr-Val/Ile/Leu-Leu-Ser-Leu-Ser-Val/Ile/Leu 
Ion assignement: 
 
m/z 1126 peak 1:C
10
FA-Leu-Glu-Thr-Ile/Leu-Leu-Ser-Leu-Ser-Val; Massetolide L 
m/z 1126 peak 2: C
10
FA-Leu-Glu-Thr-Val-Leu-Ser-Leu-Ser-Ile/leu; Massetolide F or Viscosin 
m/z 1140 peak 1:C
10
FA-Leu-Glu-Thr-Ile/Leu-Leu-Ser-Leu-Ser-Ile/Leu; Massetolide A or D 
m/z 1154 peak 1: C
12
FA-Leu-Glu-Thr-Ile/Leu-Leu-Ser-Leu-Ser-Val; Massetolide L 
m/z 1154 peak 2: C
12
FA-Leu-Glu-Thr-Val-Leu-Ser-Leu-Ser-Ile/leu; Massetolide F or Viscosin 
m/z 1168 peak 1: C
12
FA-Leu-Glu-Thr-Ile/Leu-Leu-Ser-Leu-Ser-Ile/Leu; Massetolide A or D 
m/z 1168 
m/z 1154 
m/z 1140 
m/z 1126 
